Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Medicare Remains Vulnerable to Fraud, Waste, and Abuse Related to Off-the-Shelf Orthotic Braces, Which May Result in Improper Payments and Impact the Health of Enrollees

Issued on  | Posted on  | Report number: A-09-21-03019

Report Materials

Why OIG Prepared This Portfolio

From calendar years (CYs) 2014 through 2020, Medicare paid approximately $5.3 billion for orthotic braces provided to Medicare enrollees. The Centers for Medicare & Medicaid Services (CMS) found that orthotic braces were consistently among the top 20 items of durable medical equipment, prosthetics, orthotics, and supplies with the highest improper payment rates. Adequate CMS oversight is critical in ensuring that Medicare enrollees continue to have access to and receive medically necessary braces.

This portfolio provides an overview of vulnerabilities identified in prior Office of Inspector General (OIG) audits, evaluations, and investigations and issues identified in our analysis of Medicare claims data related to off-the-shelf (OTS) orthotic braces from CYs 2018 through 2020.

Issues Identified in This Portfolio

Based on our review of the vulnerabilities identified in OIG’s prior work and our analysis of Medicare claims data, we identified issues related to CMS’s oversight of OTS braces, including the following: (1) providers ordered braces for enrollees for whom there was no history of a treating relationship, (2) new suppliers were located in geographic areas with known Medicare fraud, (3) Medicare paid more than private payers for OTS braces, and (4) suppliers used prohibited solicitation to contact enrollees.

These issues continue to put Medicare and its enrollees at risk and demonstrate the need for CMS to strengthen its oversight related to supplier billing requirements, ordering provider requirements, supplier enrollment and monitoring, Medicare allowable amounts for OTS braces, telemarketing to Medicare enrollees, and fraud related to OTS braces. If not addressed, these issues could result in improper payments, potential enrollee harm, and Medicare paying more than non-Medicare payers, such as private insurance companies, for OTS braces.

What Action Is Needed and CMS Comments

To reduce the risk of fraud, waste, and abuse related to OTS braces and to protect the health of Medicare enrollees, we recommend that CMS strengthen its oversight of Medicare billing for OTS braces by: (1) taking steps to prevent payments for claims for replacement OTS braces billed without required modifiers; (2) identifying providers who ordered OTS braces for enrollees with whom they had no treating relationships, and use that information to determine whether to provide additional education to or take administrative or legal action against the ordering providers or associated suppliers; (3) analyzing supplier billing patterns to determine whether to conduct additional prepayment or postpayment reviews of suppliers; (4) ensuring that Medicare allowable amounts are reasonably comparable with payments made by non-Medicare payers; (5) educating suppliers and enrollees on telemarketing practices for OTS braces; and (6) using predictive data analysis and information from other Federal agencies and from State agencies to identify emerging fraud schemes related to OTS braces, and using CMS’s authority to prevent further losses to the Medicare program.

CMS did not state whether it concurred with our recommendations but described its efforts to reduce and prevent improper payments related to OTS braces.

24-A-09-079.01 to CMS - Closed Implemented
Closed on 08/28/2024
We recommend that the Centers for Medicare & Medicaid Services determine why claims that did not have the required modifiers were paid for replacement OTS braces, and take steps to prevent payments for such claims.

24-A-09-079.02 to CMS - Closed Implemented
Closed on 10/03/2024
We recommend that the Centers for Medicare & Medicaid Services identify providers who ordered OTS braces for enrollees with whom they had no treating relationships and use that information to determine whether to provide additional education to—or take administrative or legal action against—the ordering providers or associated suppliers.

24-A-09-079.03 to CMS - Closed Implemented
Closed on 10/03/2024
We recommend that the Centers for Medicare & Medicaid Services analyze supplier billing patterns and use that information to determine whether to conduct additional prepayment or postpayment reviews of suppliers or impose a temporary moratorium on enrolling new suppliers of OTS braces if CMS determines that there is significant potential for fraud, waste, or abuse.

24-A-09-079.04 to CMS - Closed Superseded
Closed on 10/02/2024
We recommend that the Centers for Medicare and Medicaid Services review Medicare allowable amounts for OTS braces that are not currently in the DMEPOS Competitive Bidding Program to ensure that Medicare payments for OTS braces are reasonably comparable with payments made by non-Medicare payers, and determine whether to include any of those procedure codes for braces in future rounds of competitive bidding.

24-A-09-079.05 to CMS - Open Unimplemented
Update expected on 11/23/2024
We recommend that the Centers for Medicare & Medicaid Services educate suppliers and enrollees on telemarketing practices for OTS braces, specifically on not using direct solicitation of enrollees, and consider revoking billing privileges of suppliers that engage in prohibited solicitation practices.

24-A-09-079.06 to CMS - Closed Implemented
Closed on 10/03/2024
We recommend that the Centers for Medicare & Medicaid Services use predictive data analysis and information from other Federal agencies and from State agencies to identify emerging fraud schemes related to OTS braces, and use CMS's authority to prevent further losses to the Medicare program.

View in Recommendation Tracker